PACS Co Fndr; Exec V Chair Mark Hancock Sells $5.6M of Stock

Mark Hancock, Co-Founder and Executive Vice Chair of PACS Group, Inc. (NYSE:PACS), sold 138,069 shares of the company on June 25, 2026. The shares were sold at an average price of $40.33 each, amounting to a total transaction value of about $5.57 million. This sale was part of a planned transaction.

Insider Buying and Selling at PACS Group, Inc.

Recent insider activity at PACS Group has seen Mark Hancock making several planned sales. On June 26, he sold an additional 61,931 shares at an average price of $40.50. Earlier in June, Hancock executed multiple planned sales, including 63,680 shares on June 17 at $35.30 and 83,066 shares on June 16 at $35.90. Chief Accounting Officer Michelle Renee Lewis also sold 15,000 shares at $40.01 on June 25.

Other Institutional Activity in PACS Group

Institutional investors have shown varied activity in PACS Group. Cohen & Steers, Inc. decreased its holdings by 374,641 shares, leaving it with 9,123,136 shares valued at approximately $293.04 million. FMR LLC increased its position by 462,279 shares, bringing its total to 5,247,892 shares worth about $168.56 million. BlackRock, Inc. reduced its stake by 112,583 shares, holding 3,775,290 shares valued at $121.26 million. Alyeska Investment Group, L.P. boosted its holdings by 752,664 shares to 3,002,671 shares, valued at $96.45 million. Crewe Advisors LLC added 606,364 shares, totaling 2,754,179 shares worth around $88.46 million.

PACS Group, Inc. Stock Down 12.3%

Shares of PACS Group traded near $40.68 on Saturday. The company has a market capitalization of about $6.44 billion and a P/E ratio of 26.2. Over the past year, the stock has ranged from a low of $7.50 to a high of $43.08. Its 50-day moving average is $36.08, while the 200-day moving average is $29.68. The company maintains a current ratio of 0.995 and a quick ratio of 0.914, with a debt-to-equity ratio of 336.46.

Recent Earnings

In its most recent earnings report, PACS Group reported revenue of $5.43 billion, reflecting a growth rate of 11.2%. The company's net margin stood at 4.5%, with a return on equity of 27.1%. The earnings per share (EPS) was reported at $1.55. PACS Group is expected to announce its next earnings results on May 11, 2026.

Analysts Set New Price Targets

Analysts have maintained a strong buy rating on PACS Group. On May 18, 2026, Truist Securities maintained its buy rating with a price target of $52. Oppenheimer reiterated its buy rating on May 13 with a $48 target. UBS maintained a buy rating with a $44 target on March 4. The consensus among analysts is a strong buy, with a mean price target of $49.67 based on six opinions.

About PACS Group

PACS Group, Inc. operates in the healthcare sector, focusing on skilled nursing and assisted living facilities across the United States. The company, headquartered in Salt Lake City, Utah, also engages in the acquisition and leasing of healthcare-related properties. Founded in 2013, PACS Group employs around 47,455 people and is led by CEO Mr. Jason Murray.

Bottom Line

Mark Hancock's recent sale of shares in PACS Group is part of a planned transaction, highlighting ongoing insider activity. The company's stock performance, with a stable price near $40.68 and a strong buy consensus from analysts, draws investor interest. Remember, 13F filings and insider reports provide a historical view and may not reflect current positions.